Telomir Pharmaceuticals Inc (TELO)

Finanzdaten der Telomir Pharmaceuticals Inc-Aktie (TELO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	57.77%0.75	1.76	1.04	2.13	1.15
Research and Development	43.35%0.25	0.44	0.47	1.30	0.76
	59.03%-0.71	-1.72	-0.99	-2.06	-1.10
Attributable To Parent	59.03%-0.71	-1.72	-0.99	-2.06	-1.10
Available To Common Stockholders, Basic	98.53%-0.71	-47.84	-	-	-1.10
Preferred Stock Dividends And Other Adjustments	100.00%-	46.11	-	-	-
Basic Average Shares	13.05%68.77	60.84	34.38	-	32.40
Diluted Average Shares	13.05%68.77	60.84	34.38	-	32.40
Basic Earnings Per Share	98.73%-0.01	-0.79	-0.03	-	-0.03
Diluted Earnings Per Share	98.73%-0.01	-0.79	-0.03	-	-0.03